IQVIA™ (NYSE:IQV) today announced that the Angels Initiative for improving care for stroke patients has been awarded the 2018 Health Collaboration Award for Best Service Delivery by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The Angels Initiative is a non-commercial healthcare program by Boehringer Ingelheim, in Europe in close collaboration with IQVIA focused on improving stroke care. The project is endorsed by the European Stroke Organisation and World Stroke Organisation as well as the Stroke Alliance for Europe (SAFE), RESQ, SITS, QASC Europe, Medtronic, Brainomix and many other institutions and communities dedicated to improving stroke care globally. IQVIA’s management and administration of the initiative includes: hospital enrollment, on-site consultancy, as well as training and education of healthcare professionals regarding stroke-patient care.
“We are very pleased with the quality of the work and the motivation of the IQVIA Angels consultants. The collaboration with IQVIA contributes significantly to the success of Angels,” commented Thomas Fischer, Head of the Global Angels Initiative.
Reviewing more than 80 applications, an esteemed jury appointed by EFPIA selected the Angels Initiative as a program of distinction, describing it as, "a very impressive strategic project with clear objectives and excellent collaboration across a wide range of countries and stakeholders.”
The overall strategy of the Angels Initiative is to increase the number of “stroke-ready” hospitals and to optimize the quality of treatment in existing stroke centers. A crucial element of the implementation of the initiative are the Angels Consultants spending time with doctors, nurses and ambulance crews to create and improve the treatment pathways and processes around stroke care.
“Only in Europe every 30 minutes, a stroke patient dies or is permanently disabled — not only due to the stroke itself, but because they were treated in the wrong hospital. This initiative seeks to change that,” said Chris Pepler, senior vice president, Contract Sales and Medical Solutions at IQVIA. “As part of this initiative, IQVIA is delighted to see our efforts recognized by the EFPIA and, together with collaborating organizations, we will continue to strive to improve stroke care worldwide.”
Since its launch in 2017, the Angels Initiative has enrolled nearly 2500 hospitals from more than 60 countries, positively affecting the treatment of 1.3 million stroke patients.
Additional information about the Angels Initiative is available at https://www.angels-initiative.com/.
The Angels Initiative is a non-commercial healthcare program by Boehringer Ingelheim, in Europe in close collaboration with IQVIA focused on improving stroke care. The project is endorsed by the European Stroke Organisation and World Stroke Organisation as well as the Stroke Alliance for Europe (SAFE), RESQ, SITS, QASC Europe, Medtronic, Brainomix and many other institutions and communities dedicated to improving stroke care globally. IQVIA’s management and administration of the initiative includes: hospital enrollment, on-site consultancy, as well as training and education of healthcare professionals regarding stroke-patient care.
“We are very pleased with the quality of the work and the motivation of the IQVIA Angels consultants. The collaboration with IQVIA contributes significantly to the success of Angels,” commented Thomas Fischer, Head of the Global Angels Initiative.
Reviewing more than 80 applications, an esteemed jury appointed by EFPIA selected the Angels Initiative as a program of distinction, describing it as, "a very impressive strategic project with clear objectives and excellent collaboration across a wide range of countries and stakeholders.”
The overall strategy of the Angels Initiative is to increase the number of “stroke-ready” hospitals and to optimize the quality of treatment in existing stroke centers. A crucial element of the implementation of the initiative are the Angels Consultants spending time with doctors, nurses and ambulance crews to create and improve the treatment pathways and processes around stroke care.
“Only in Europe every 30 minutes, a stroke patient dies or is permanently disabled — not only due to the stroke itself, but because they were treated in the wrong hospital. This initiative seeks to change that,” said Chris Pepler, senior vice president, Contract Sales and Medical Solutions at IQVIA. “As part of this initiative, IQVIA is delighted to see our efforts recognized by the EFPIA and, together with collaborating organizations, we will continue to strive to improve stroke care worldwide.”
Since its launch in 2017, the Angels Initiative has enrolled nearly 2500 hospitals from more than 60 countries, positively affecting the treatment of 1.3 million stroke patients.
Additional information about the Angels Initiative is available at https://www.angels-initiative.com/.
